BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 30600644)

  • 21. Antiviral Activities of Silymarin and Derivatives.
    Liu CH; Jassey A; Hsu HY; Lin LT
    Molecules; 2019 Apr; 24(8):. PubMed ID: 31010179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. De novo design approaches targeting an envelope protein pocket to identify small molecules against dengue virus.
    Leal ES; Adler NS; Fernández GA; Gebhard LG; Battini L; Aucar MG; Videla M; Monge ME; Hernández de Los Ríos A; Acosta Dávila JA; Morell ML; Cordo SM; García CC; Gamarnik AV; Cavasotto CN; Bollini M
    Eur J Med Chem; 2019 Nov; 182():111628. PubMed ID: 31472473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In-silico identification and evaluation of plant flavonoids as dengue NS2B/NS3 protease inhibitors using molecular docking and simulation approach.
    Qamar MT; Ashfaq UA; Tusleem K; Mumtaz A; Tariq Q; Goheer A; Ahmed B
    Pak J Pharm Sci; 2017 Nov; 30(6):2119-2137. PubMed ID: 29175781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design and synthesis of imidazolidinone derivatives as potent anti-leishmanial agents by bioisosterism.
    Ramu D; Jain R; Kumar RR; Sharma V; Garg S; Ayana R; Luthra T; Yadav P; Sen S; Singh S
    Arch Pharm (Weinheim); 2019 Apr; 352(4):e1800290. PubMed ID: 30801775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel symmetrical phenylenediamines as potential anti-hepatitis C virus agents.
    Bassetto M; Ferla S; Leyssen P; Neyts J; Yerukhimovich MM; Frick DN; O'Donnell R; Brancale A
    Antivir Chem Chemother; 2015 Dec; 24(5-6):155-160. PubMed ID: 27815332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The antiviral effect of 7-hydroxyisoflavone against Enterovirus 71 in vitro.
    Wang HQ; Meng S; Li ZR; Peng ZG; Han YX; Guo SS; Cui XL; Li YH; Jiang JD
    J Asian Nat Prod Res; 2013; 15(4):382-9. PubMed ID: 23464760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phenylalanine and Phenylglycine Analogues as Arginine Mimetics in Dengue Protease Inhibitors.
    Weigel LF; Nitsche C; Graf D; Bartenschlager R; Klein CD
    J Med Chem; 2015 Oct; 58(19):7719-33. PubMed ID: 26367391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dual inhibition of HCV and HIV by ring-expanded nucleosides containing the 5:7-fused imidazo[4,5-e][1,3]diazepine ring system. In vitro results and implications.
    Zhang N; Zhang P; Baier A; Cova L; Hosmane RS
    Bioorg Med Chem Lett; 2014 Feb; 24(4):1154-7. PubMed ID: 24461293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery and development of VX-950, a novel, covalent, and reversible inhibitor of hepatitis C virus NS3.4A serine protease.
    Lin C; Kwong AD; Perni RB
    Infect Disord Drug Targets; 2006 Mar; 6(1):3-16. PubMed ID: 16787300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In silico evaluation of inhibitory potential of triterpenoids from Azadirachta indica against therapeutic target of dengue virus, NS2B-NS3 protease.
    Dwivedi VD; Tripathi IP; Mishra SK
    J Vector Borne Dis; 2016; 53(2):156-61. PubMed ID: 27353586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and Structure-Activity Relationships of Diarylhydrazides as Novel Potent and Selective Human Enterovirus Inhibitors.
    Han X; Sun N; Wu H; Guo D; Tien P; Dong C; Wu S; Zhou HB
    J Med Chem; 2016 Mar; 59(5):2139-50. PubMed ID: 26885567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Flavonoids as noncompetitive inhibitors of Dengue virus NS2B-NS3 protease: inhibition kinetics and docking studies.
    de Sousa LR; Wu H; Nebo L; Fernandes JB; da Silva MF; Kiefer W; Kanitz M; Bodem J; Diederich WE; Schirmeister T; Vieira PC
    Bioorg Med Chem; 2015 Feb; 23(3):466-70. PubMed ID: 25564380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toward the Synthesis of Fluorinated Analogues of HCV NS3/4A Serine Protease Inhibitors Using Methyl α-Amino-β-fluoro-β-vinylcyclopropanecarboxylate as Key Intermediate.
    Milanole G; Andriessen F; Lemonnier G; Sebban M; Coadou G; Couve-Bonnaire S; Bonfanti JF; Jubault P; Pannecoucke X
    Org Lett; 2015 Jun; 17(12):2968-71. PubMed ID: 26053226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure-guided Discovery of a Novel Non-peptide Inhibitor of Dengue Virus NS2B-NS3 Protease.
    Li L; Basavannacharya C; Chan KW; Shang L; Vasudevan SG; Yin Z
    Chem Biol Drug Des; 2015 Sep; 86(3):255-64. PubMed ID: 25533891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potent inhibitors of the hepatitis C virus NS3 protease: use of a novel P2 cyclopentane-derived template.
    Johansson PO; Bäck M; Kvarnström I; Jansson K; Vrang L; Hamelink E; Hallberg A; Rosenquist A; Samuelsson B
    Bioorg Med Chem; 2006 Aug; 14(15):5136-51. PubMed ID: 16675222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Linear and branched alkyl-esters and amides of gallic acid and other (mono-, di- and tri-) hydroxy benzoyl derivatives as promising anti-HCV inhibitors.
    Rivero-Buceta E; Carrero P; Doyagüez EG; Madrona A; Quesada E; Camarasa MJ; Peréz-Pérez MJ; Leyssen P; Paeshuyse J; Balzarini J; Neyts J; San-Félix A
    Eur J Med Chem; 2015 Mar; 92():656-71. PubMed ID: 25617695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and antiviral activity of novel HCV NS3 protease inhibitors with P4 capping groups.
    Li X; Liu Y; Zhang YK; Plattner JJ; Baker SJ; Bu W; Liu L; Zhou Y; Ding CZ; Zhang S; Kazmierski WM; Hamatake R; Duan M; Wright LL; Smith GK; Jarvest RL; Ji JJ; Cooper JP; Tallant MD; Crosby RM; Creech K; Wang A
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7351-6. PubMed ID: 23142614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and biological evaluation of acyclic phosphonic acid nucleoside derivatives.
    Wainwright P; Maddaford A; Zhang X; Billington H; Leese D; Glen R; Pryde DC; Middleton DS; Stephenson PT; Sutton S
    Nucleosides Nucleotides Nucleic Acids; 2013; 32(9):477-92. PubMed ID: 24079272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis of Pyrazine-1,3-thiazine Hybrid Analogues as Antiviral Agent Against HIV-1, Influenza A (H1N1), Enterovirus 71 (EV71), and Coxsackievirus B3 (CVB3).
    Wu HM; Zhou K; Wu T; Cao YG
    Chem Biol Drug Des; 2016 Sep; 88(3):411-21. PubMed ID: 27062664
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel dengue virus NS2B/NS3 protease inhibitors.
    Wu H; Bock S; Snitko M; Berger T; Weidner T; Holloway S; Kanitz M; Diederich WE; Steuber H; Walter C; Hofmann D; Weißbrich B; Spannaus R; Acosta EG; Bartenschlager R; Engels B; Schirmeister T; Bodem J
    Antimicrob Agents Chemother; 2015 Feb; 59(2):1100-9. PubMed ID: 25487800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.